These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35380399)

  • 1. The Antiepileptic Valproic Acid Ameliorates Charcot-Marie-Tooth 2W (CMT2W) Disease-Associated HARS1 Mutation-Induced Inhibition of Neuronal Cell Morphological Differentiation Through c-Jun N-terminal Kinase.
    Memezawa S; Sato T; Ochiai A; Fukawa M; Sawaguchi S; Sango K; Miyamoto Y; Yamauchi J
    Neurochem Res; 2022 Sep; 47(9):2684-2702. PubMed ID: 35380399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathy-associated histidyl-tRNA synthetase variants attenuate protein synthesis in vitro and disrupt axon outgrowth in developing zebrafish.
    Mullen P; Abbott JA; Wellman T; Aktar M; Fjeld C; Demeler B; Ebert AM; Francklyn CS
    FEBS J; 2021 Jan; 288(1):142-159. PubMed ID: 32543048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CMT type 2N disease-associated AARS mutant inhibits neurite growth that can be reversed by valproic acid.
    Tatsumi Y; Matsumoto N; Iibe N; Watanabe N; Torii T; Sango K; Homma K; Miyamoto Y; Sakagami H; Yamauchi J
    Neurosci Res; 2019 Feb; 139():69-78. PubMed ID: 30261202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mood stabilizer valproic acid improves defective neurite formation caused by Charcot-Marie-Tooth disease-associated mutant Rab7 through the JNK signaling pathway.
    Yamauchi J; Torii T; Kusakawa S; Sanbe A; Nakamura K; Takashima S; Hamasaki H; Kawaguchi S; Miyamoto Y; Tanoue A
    J Neurosci Res; 2010 Nov; 88(14):3189-97. PubMed ID: 20645406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variants of aminoacyl-tRNA synthetase genes in Charcot-Marie-Tooth disease: A Korean cohort study.
    Nam DE; Park JH; Park CE; Jung NY; Nam SH; Kwon HM; Kim HS; Kim SB; Son WS; Choi BO; Chung KW
    J Peripher Nerv Syst; 2022 Mar; 27(1):38-49. PubMed ID: 34813128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CMT disease severity correlates with mutation-induced open conformation of histidyl-tRNA synthetase, not aminoacylation loss, in patient cells.
    Blocquel D; Sun L; Matuszek Z; Li S; Weber T; Kuhle B; Kooi G; Wei N; Baets J; Pan T; Schimmel P; Yang XL
    Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19440-19448. PubMed ID: 31501329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Morant L; Erfurth ML; Jordanova A
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional dysregulation by a nucleus-localized aminoacyl-tRNA synthetase associated with Charcot-Marie-Tooth neuropathy.
    Bervoets S; Wei N; Erfurth ML; Yusein-Myashkova S; Ermanoska B; Mateiu L; Asselbergh B; Blocquel D; Kakad P; Penserga T; Thomas FP; Guergueltcheva V; Tournev I; Godenschwege T; Jordanova A; Yang XL
    Nat Commun; 2019 Nov; 10(1):5045. PubMed ID: 31695036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodegenerative Charcot-Marie-Tooth disease as a case study to decipher novel functions of aminoacyl-tRNA synthetases.
    Wei N; Zhang Q; Yang XL
    J Biol Chem; 2019 Apr; 294(14):5321-5339. PubMed ID: 30643024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMT-associated mutations in glycyl- and tyrosyl-tRNA synthetases exhibit similar pattern of toxicity and share common genetic modifiers in Drosophila.
    Ermanoska B; Motley WW; Leitão-Gonçalves R; Asselbergh B; Lee LH; De Rijk P; Sleegers K; Ooms T; Godenschwege TA; Timmerman V; Fischbeck KH; Jordanova A
    Neurobiol Dis; 2014 Aug; 68():180-9. PubMed ID: 24807208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histidine supplementation can escalate or rescue HARS deficiency in a Charcot-Marie-Tooth disease model.
    Qiu Y; Kenana R; Beharry A; Wilhelm SDP; Hsu SY; Siu VM; Duennwald M; Heinemann IU
    Hum Mol Genet; 2023 Feb; 32(5):810-824. PubMed ID: 36164730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular genetics of inherited neuropathies].
    Takashima H
    Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoacyl-tRNA synthetases in Charcot-Marie-Tooth disease: A gain or a loss?
    Zhang H; Zhou ZW; Sun L
    J Neurochem; 2021 May; 157(3):351-369. PubMed ID: 33236345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate interaction defects in histidyl-tRNA synthetase linked to dominant axonal peripheral neuropathy.
    Abbott JA; Meyer-Schuman R; Lupo V; Feely S; Mademan I; Oprescu SN; Griffin LB; Alberti MA; Casasnovas C; Aharoni S; Basel-Vanagaite L; Züchner S; De Jonghe P; Baets J; Shy ME; Espinós C; Demeler B; Antonellis A; Francklyn C
    Hum Mutat; 2018 Mar; 39(3):415-432. PubMed ID: 29235198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N).
    McLaughlin HM; Sakaguchi R; Giblin W; ; Wilson TE; Biesecker L; Lupski JR; Talbot K; Vance JM; Züchner S; Lee YC; Kennerson M; Hou YM; Nicholson G; Antonellis A
    Hum Mutat; 2012 Jan; 33(1):244-53. PubMed ID: 22009580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Charcot-Marie-Tooth disease and related inherited neuropathies.
    Murakami T; Garcia CA; Reiter LT; Lupski JR
    Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Searching for non-canonical functions of aminoacyl-tRNA synthases based on mutations carried by Charcot-Marie-Tooth patients].
    Misiorek JO
    Postepy Biochem; 2023 Mar; 69(1):42-46. PubMed ID: 37493554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutations.
    Stum M; McLaughlin HM; Kleinbrink EL; Miers KE; Ackerman SL; Seburn KL; Antonellis A; Burgess RW
    Mol Cell Neurosci; 2011 Feb; 46(2):432-43. PubMed ID: 21115117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alanyl-tRNA synthetase 1 (AARS1) gene mutation in a family with intermediate Charcot-Marie-Tooth neuropathy.
    Lee AJ; Nam DE; Choi YJ; Nam SH; Choi BO; Chung KW
    Genes Genomics; 2020 Jun; 42(6):663-672. PubMed ID: 32314272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.